Crossmark

Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliability

Crossref DOI link: https://doi.org/10.1186/s12871-019-0846-z

Published Online: 2019-09-06

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dirkmann, Daniel http://orcid.org/0000-0003-0118-1889
Nagy, Elisabeth

Britten, Martin W.

Peters, Jürgen
License Information

Text and Data Mining valid from 2019-09-06

Version of Record valid from 2019-09-06
More Information

Article History

Received: 25 December 2018

Accepted: 28 August 2019

First Online: 6 September 2019

Ethics approval and consent to participate

: Ethics committee approval (Ethik-Komission der Universität Duisburg Essen, Robert-Koch-Straße 9–11, D-45147 Essen, Germany, protocol no. 16–7027-BO) was obtained and the need to obtain written consent of the patients was waived by the ethics committee because of the pseudonymisation and kind of study.

: Not applicable.

: DD and MB received honoraria for scientific lectures and / or travel support from CSL Behring GmbH, Marburg, Germany. DD received honoraria for scientific lectures and / or travel support from Abbott Point of Care, Princeton, NJ, USA, TEM international GmbH Munich, Germany, and was member of a Scientific Advisiory Committee for Werfen, Barcelona, Spain.

Document is current

Any future updates will be listed below